1.Migraine and ischemic stroke
Guangya JIANG ; Chunling LIU ; Yu LOUJI
International Journal of Cerebrovascular Diseases 2011;19(12):916-920
Migraine is a common neurovascular disease in clinical practice,its pathogenesis is both involved in the nervous system and vascular system.Many researchers believe that there are complex relationships between migraine and ischemic stroke.This article reviews the advances in this field in recent years.
2.Preparation and Properties of Mesalazine β-Cyclodextrin Inclusion Compound
Chunling JIANG ; Conghai LIU ; Chenggui ZHANG ; Hengyuan XIE ; Guangya CAI ; Ya ZHOU ; Shi CHEN
China Pharmacist 2017;20(2):266-270
Objective:To prepare mesalazineβ-cyclodextrin inclusion compound and observe its properties. Methods:The struc-ture was characterized by UV, IR and DSC. The inclusion process of mesalazine andβ-cyclodextrin was simulated using molecular doc-king technique. The solubility and dissolution of inclusion compound were determined. Results:UV, IR and DSC were used to deter-mine the formation of inclusion complex. The inclusion ratio was 1: 1 and the phase solubility diagram was AL type. The solubility of inclusion compound in deionized water (25 ℃, pH 7. 0) was 7. 8 mg·ml-1 . The preparation of mesalazine β-cyclodextrin inclusion compound could significantly increase the dissolution rate and solubility of mesalazine. Conclusion:The prepared mesalazineβ-cyclo-dextrin inclusion compound can obviously improve the poor water solubility and dissolution of mesalazine.
3.Advances of enzymes in the applications of disease treatment and drug preparation.
Rui ZHOU ; Xin LIU ; Bo ZENG ; Wei JIANG ; Guangya ZHANG
Chinese Journal of Biotechnology 2021;37(7):2256-2271
The development of biotechnology and the in-depth research on disease mechanisms have led to increased application of enzymes in the treatment of diseases. In addition, enzymes have shown great potential in drug manufacturing, particularly in production of non-natural organic compounds, due to the advantages of mild reaction conditions, high catalytic efficiency, high specificity, high selectivity and few side reactions. Moreover, the application of genetic engineering, chemical modification of enzymes and immobilization technologies have further improved the function of enzymes. This review summarized the advances of using enzymes as drugs for disease treatment or as catalysts for drug manufacturing, followed by discussing challenges, potential solutions and future perspectives on the application of enzymes in the medical and pharmaceutical field.
Biocatalysis
;
Biotechnology
;
Catalysis
;
Drug Compounding
;
Enzymes/metabolism*